Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 Pons Pons +31.37%
#3 龙虾 (Lobster) 龙虾 (Lobster) +31.15%
#4 Rain Rain +30.32%
#5 MetaDAO MetaDAO +27.10%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +23.16%
#7 Bedrock Bedrock +20.67%
#8 Ontology Gas Ontology Gas +16.20%
#9 Prom Prom +15.79%
#10 peaq peaq +15.07%
Coin of the day
QuantixAI QuantixAI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Chemical Works Chemical Works

Chemical Works

RICHT
Clasificación en acciones #2662
Chemical Works of Gedeon Richter Plc engages in the development and manufacture... Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Precio por acción
$41.81
Capitalización bursátil
$7.65B
Cambio (1 día)
0.23%
Cambio (1 año)
34.96%
País
HU
Comercio Chemical Works (RICHT)

Categoría

Healthcare
Ingresos de Chemical Works (RICHT)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Chemical Works, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Chemical Works desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK